doctors – 37 Miles

The information on this page is intended for healthcare professionals and aligns with current ethical and scientific standards. All treatments referenced should be prescribed and administered within the legal and ethical parameters of medical practice.

How 37 Miles supports your clinical practice

At 37 Miles, we specialize in facilitating safe, science-based access to innovative therapies that are not yet part of the standard prescription landscape. Our mission is to bridge the gap between emerging evidence and clinical application — empowering healthcare providers with new therapeutic tools for complex cases.

We support your practice by connecting you and your patients to:

Medical cannabis therapies

Psychedelic-assisted treatments (where legally authorized)

Specialty medications for complex conditions

Virtual reality-based therapeutic protocols

How We Help

Up-to-date information on therapeutic possibilities, clinical protocols, and regulatory pathways

Document support for patients seeking to access or import therapies under medical supervision

Technical guidance throughout the process, ensuring safe, evidence-informed use of emerging treatments

Want to prescribe, but need to get up to speed?

37 Miles empowers your patients — and respects your autonomy — by offering support that aligns with global ethical standards and current evidence. Here’s how we contribute to your work:

Summaries of the latest scientific literature and clinical trials
Template protocols and best practices
Documentation models for patient access and treatment follow-up
Educational resources tailored to your specialty

Scientific Foundations Behind Our Work

Our medical and research team follows key studies and publications in areas such as:

The Health Effects of Cannabis and Cannabinoids

National Academies of Sciences, Engineering, and Medicine (2017) A comprehensive review of therapeutic benefits and risks related to cannabinoids. View Report – National Academies Press

Click Here

Trial of Psilocybin vs. Escitalopram for Depression

New England Journal of Medicine (2021) Randomized trial comparing psilocybin to a standard antidepressant in patients with moderate to severe depression. Read the Study – NEJM

Click Here

Virtual Reality in Pain Management

PubMed-indexed studies & Reducept protocols Numerous studies demonstrate the efficacy of virtual reality as an adjunct tool in managing chronic pain. Key example: Mallari B et al. (2019). Virtual reality as an analgesic for acute and chronic pain: a systematic review and meta-analysis.

View in PubMed